4.6 Review

Transient Receptor Potential Ankyrin 1 (TRPA1) Channel as a Sensor of Oxidative Stress in Cancer Cells

Journal

CELLS
Volume 12, Issue 9, Pages -

Publisher

MDPI
DOI: 10.3390/cells12091261

Keywords

cancer; reactive oxygen species; hydrogen peroxide; Transient Receptor Potential Ankyrin 1; Ca2+ signaling; nuclear factor erythroid 2-related factor 2; antioxidant defense; apoptosis

Categories

Ask authors/readers for more resources

Moderate levels of ROS can promote tumor metastasis and invasion, while excessive levels of ROS can impair tumor growth and metastasis by inducing cancer cell death. Malignant cells have developed a sophisticated antioxidant defense mechanism to cope with oxidative stress. Targeting the antioxidant capacity of cancer cells or enhancing their sensitivity to ROS-dependent cell death can be a promising alternative anticancer treatment strategy.
Moderate levels of reactive oxygen species (ROS), such as hydrogen peroxide (H2O2), fuel tumor metastasis and invasion in a variety of cancer types. Conversely, excessive ROS levels can impair tumor growth and metastasis by triggering cancer cell death. In order to cope with the oxidative stress imposed by the tumor microenvironment, malignant cells exploit a sophisticated network of antioxidant defense mechanisms. Targeting the antioxidant capacity of cancer cells or enhancing their sensitivity to ROS-dependent cell death represent a promising strategy for alternative anticancer treatments. Transient Receptor Potential Ankyrin 1 (TRPA1) is a redox-sensitive non-selective cation channel that mediates extracellular Ca2+ entry upon an increase in intracellular ROS levels. The ensuing increase in intracellular Ca2+ concentration can in turn engage a non-canonical antioxidant defense program or induce mitochondrial Ca2+ dysfunction and apoptotic cell death depending on the cancer type. Herein, we sought to describe the opposing effects of ROS-dependent TRPA1 activation on cancer cell fate and propose the pharmacological manipulation of TRPA1 as an alternative therapeutic strategy to enhance cancer cell sensitivity to oxidative stress.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available